Effect of riboflavin status on hepatic activities of flavin-metabolizing enzymes in rats.
The effect of riboflavin status on hepatic activities of the relatively substrate-specific flavokinase and FAD synthetase and the relatively nonspecific FMN phosphatase and FAD pyrophosphatase was investigated in weanling, male Sprague-Dawley rats fed 0, 5, 15, 30 and 60 micrograms riboflavin/15 g diet for 1, 3 and 5 weeks. Flavokinase activity was determined by using [14C]riboflavin and ATP as substrates and measuring product [14C]FMN after incubation and separation by high performance liquid chromatography. Similarly, FAD synthetase activity was determined by using [3H]ATP and FMN and quantitating [3H]FAD formed. Flavokinase activities among all groups were similar after only 1 week of feeding experimental diets; by 3 weeks, activities were depressed to about 60% of normal in animals that received suboptimal riboflavin; by 5 weeks, activity of rats fed riboflavin-free diet was further decreased to about 40% of normal. FAD synthetase activities were unaffected by riboflavin status at 1 and 3 weeks; however, at 5 weeks, activities were moderately decreased to 85, 65 and 52% of normal with rats which had received 15, 5 and 0 microgram riboflavin/15 g diet, respectively. FMN phosphatase and FAD pyrophosphatase activities decreased with age, but were not influenced by riboflavin status at any period. Overall results indicate the effect of increasing severity of riboflavin deficiency is greater with flavokinase, which is physiologically rate-limiting in the biosynthesis of flavocoenzymes, than with FAD synthetase.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D008099:Liver / Q000201:enzymology*; D008297:Male; D009708:Nucleotidases / Q000378:metabolism*; D009713:Nucleotidyltransferases / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism*; D017853:Phosphotransferases (Alcohol Group Acceptor); D011755:Pyrophosphatases / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012256:Riboflavin / Q000008:administration & dosage / Q000378:metabolism*; D012257:Riboflavin Deficiency / Q000201:enzymology; D013347:Subcellular Fractions / Q000201:enzymology
D010770:Phosphotransferases; D017853:Phosphotransferases (Alcohol Group Acceptor); C022532:riboflavin kinase; D009713:Nucleotidyltransferases; C020143:FMN adenylyltransferase; C033670:FMN phosphatase; D009708:Nucleotidases; D011755:Pyrophosphatases; C023417:FAD pyrophosphatase; D012256:Riboflavin